ArticleInfluenza and other respiratory viruses2025

COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network.

Charlotte Laniece Delaunay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.